Keith Speights
TMFFishBiz
Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.
Recent Articles by Keith Speights

Nov 22, 2024
by Keith Speights
Got $500? 1 Biotech Stock to Buy and Hold Forever

Nov 21, 2024
by Keith Speights
3 No-Brainer Warren Buffett Stocks to Buy Right Now

Nov 20, 2024
by Keith Speights
Is It Time to Sell Eli Lilly and Pfizer Stocks?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.